Gene Expression Profiles in Stage II and III Colon Cancer. Application of a 128-gene signature

GSE31595

Homo sapiens

34 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

Purpose: A 128-gene signature has been proposed to predict poor outcomes in patients with stage II and III colorectal cancer. In the present study we aimed to validate this previously published 128-gene signature on external and independent data from patients with stage II and III colon cancer.

PubMed ID

22710688

Publication Title

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature.

Total Samples

Submitter’s Institution

Roskilde Hospital, University of Copenhagen

Authors

Thorsteinsson M, Kirkeby LT, Hansen R, Lund LR, Sørensen LT, Gerds TA, Jess P, Olsen J

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-31595

No rows found